Dalpiciclib (SHR-6390) hydrochloride is an orally active and highly selective inhibitor of CDK4 and 6 with IC50 values of 12.4 nM and 9.9 nM, respectively[1][2]. Dalpiciclib hydrochloride shows antitumor activity against breast cancer and esophageal squamous cell carcinoma[1][2][3][4].
Molecular Weight:
483.01
Purity:
98.22
CAS Number:
[2891598-76-6]
Formula:
C25H31ClN6O2
Target:
CDK
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted